Antiseptic compositions and methods
Assignee3M Innovative Properties Company
InventorsMatthew T. Scholz, Danli Wang, Triet M. Lu, Dong-Wei Zhu
Life of this patent
Estimating the term…
Loading patent…
Assignee3M Innovative Properties Company
InventorsMatthew T. Scholz, Danli Wang, Triet M. Lu, Dong-Wei Zhu
Estimating the term…
Antiseptic compositions, as well as methods of making and using, wherein the compositions include: an antimicrobial agent selected from the group consisting of iodine (I2), an iodophor, and a combination thereof, wherein the antimicrobial agent is present in an amount sufficient to provide an available iodine concentration of at least about 0.25 wt-%; a hydroxycarboxylic acid buffer in an amount of at least about 5 wt-%; water; and an optionally substantive film-forming polymer.
An antiseptic composition comprising:
The antiseptic composition of claim 35 wherein the anionic or amphoteric surfactant is selected from the group consisting of sulfonates, sulfates, phosphates, phosphonates, and ammonium sulfonate amphoterics, and mixtures thereof.
An antiseptic composition comprising:
An antiseptic composition comprising:
An antiseptic composition comprising:
An antiseptic composition comprising:
An antiseptic composition comprising:
A method of disinfecting tissue comprising:
A method of disinfecting tissue comprising:
A method of disinfecting tissue comprising:
A method of disinfecting tissue comprising:
A method of disinfecting tissue comprising:
A method of disinfecting tissue comprising:
A method of making an antiseptic composition, the method comprising combining components comprising:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Backward citations are indexed for grants only.
Containing heterocyclic rings having nitrogen as a ring hetero atom: polymers of vinyl pyrrolidone
Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds: iodine, e.g. iodophors; Compounds…
Containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides: carboxylic acids; Salts or anhydrides thereof
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: local antiseptics
Term end not estimated
The present invention relates to compositions that contain at least one antimicrobial agent intended primarily for tissue antisepsis, particularly skin antisepsis.
It is a standard practice in the industrialized world to disinfect the skin prior to any invasive procedure such as surgery, catheterization, or needle puncture to reduce the risk of infection. These products are often referred to as skin preps or simply “preps.” It is particularly advantageous to customers to have a single product that can be used on both in-tact skin and mucosal tissue (e.g. vaginal, oral, nasal, and ocular tissue). Other sensitive tissues that antimicrobial products have been used on include acute and chronic wounds as well as burns. For all of these skin antiseptics it is desirable to achieve a very rapid microbial reduction so that the clinician can get on with the intended procedure.
Recently, there have been several alcohol-based antiseptics on the market for both presurgical and precatherization antisepsis. These products, while good rapid acting antiseptics due to the high alcohol content (e.g., typically at least about 60 wt-%), are only suitable for use on in-tact skin and are not suitable for use on sensitive tissues such as mucosal tissue, wounds, or burn tissue.
FIG. 1. Antimicrobial activity results plotted as a function of total molar concentration of alpha-hydroxy acid.
FIG. 2. Antimicrobial activity results plotted as a function of only the concentration of lactic acid (LA)+malic acid (MA).
Desirable antiseptic compositions are aqueous-based and have the following characteristics: relatively high levels of bacterial kill; relatively short dry times; generally clear viewing of the underlying tissue; good adhesion to the skin when dry; little or no tack when dry; capable of releasing an antimicrobial agent over a period of time; good adhesion of pressure sensitive adhesive (PSA) coated products such as incise drapes, tapes, wound dressings, and the like; resist lift off of PSA-coated products while under stress as typically occurs during retraction in surgery; allow adhesion of PSA-coated products for long periods of time, e.g., hours to days; suitable for use on sensitive tissues such as mucosal tissue; and can be removed relatively easily, preferably without the need for organic solvent-based removers.
Preferred antiseptic compositions of the present invention possess all of the above-mentioned characteristics. Significantly, they provide rapid microbial kill, and they dry to low tack or nontacky films, which allow good adhesion of PSA-coated products. Furthermore, they are gentle to tissue and can be removed with a water-soaked fabric, such as a towel or simple gauze.
Furthermore, preferred compositions of the present invention are very stable and can survive prolonged exposure to elevated temperatures, e.g., 50° C. and even as high as 60° C., for prolonged periods of time, e.g., for often greater than 7 days. The most stable samples show no visible changes at all such as changes in color, turbidity, and the like. Also, preferred compositions of the present invention are very stable upon exposure to low temperatures, e.g., 4° C., and even during repeated freeze/thaw cycles, e.g., 2 or more cycles.